Cargando…

Complement Inhibitors in Clinical Trials for Glomerular Diseases

Defective complement action is a cause of several human glomerular diseases including atypical hemolytic uremic syndrome (aHUS), anti-neutrophil cytoplasmic antibody mediated vasculitis (ANCA), C3 glomerulopathy, IgA nephropathy, immune complex membranoproliferative glomerulonephritis, ischemic repe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zipfel, Peter F., Wiech, Thorsten, Rudnick, Ramona, Afonso, Sara, Person, Fermin, Skerka, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776600/ https://www.ncbi.nlm.nih.gov/pubmed/31611870 http://dx.doi.org/10.3389/fimmu.2019.02166

Ejemplares similares

Complement catalyzing glomerular diseases
por: Zipfel, Peter F., et al.
Publicado: (2021)

In situ Visualization of C3/C5 Convertases to Differentiate Complement Activation
por: Person, Fermin, et al.
Publicado: (2020)

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
por: Zhao, Fei, et al.
Publicado: (2019)

Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation
por: Stea, Emma Diletta, et al.
Publicado: (2022)

An Interdisciplinary Diagnostic Approach to Guide Therapy in C3 Glomerulopathy
por: Schmidt, Tilman, et al.
Publicado: (2022)

Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases
por: Schäfer, Nicole, et al.
Publicado: (2016)

Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells
por: Busch, Catharina, et al.
Publicado: (2023)

Enolase From Aspergillus fumigatus Is a Moonlighting Protein That Binds the Human Plasma Complement Proteins Factor H, FHL-1, C4BP, and Plasminogen
por: Dasari, Prasad, et al.
Publicado: (2019)

The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b
por: Haupt, Katrin, et al.
Publicado: (2008)

Contribution of the Infection-Associated Complement Regulator-Acquiring Surface Protein 4 (ErpC) to Complement Resistance of Borrelia burgdorferi
por: Hammerschmidt, Claudia, et al.
Publicado: (2012)

Complement in Hemolysis- and Thrombosis- Related Diseases
por: Luo, Shanshan, et al.
Publicado: (2020)

The role of the complement system in kidney glomerular capillary thrombosis
por: Yoshida, Yoko, et al.
Publicado: (2022)

CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
por: Hallström, Teresia, et al.
Publicado: (2013)

Modeling complement activation on human glomerular microvascular endothelial cells
por: Stevens, Kes H., et al.
Publicado: (2023)

A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes
por: Alic, Lejla, et al.
Publicado: (2020)

Borrelia valaisiana Resist Complement-Mediated Killing Independently of the Recruitment of Immune Regulators and Inactivation of Complement Components
por: Schwab, Jasmin, et al.
Publicado: (2013)

Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif
por: Hallström, Teresia, et al.
Publicado: (2016)

Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease
por: Caillard, Pauline, et al.
Publicado: (2023)

How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application
por: Luo, Shanshan, et al.
Publicado: (2020)

Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack
por: Hallström, Teresia, et al.
Publicado: (2015)

Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease
por: Tang, Anqi, et al.
Publicado: (2023)

Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1
por: May, Olivia, et al.
Publicado: (2018)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020)

Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
por: Duan, Suyan, et al.
Publicado: (2020)

The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement
por: Rosa, Thiago F. A., et al.
Publicado: (2015)

Factor H Binds to Extracellular DNA Traps Released from Human Blood Monocytes in Response to Candida albicans
por: Halder, Luke D., et al.
Publicado: (2017)

The Protease SplB of Staphylococcus aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis
por: Dasari, Prasad, et al.
Publicado: (2022)

Complement in glomerular injury
por: Berger, Stefan P., et al.
Publicado: (2007)

Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b
por: Koch, Tina K., et al.
Publicado: (2012)

Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway
por: Shahraz, Anahita, et al.
Publicado: (2022)

How Escherichia coli Circumvent Complement-Mediated Killing
por: Abreu, Afonso G., et al.
Publicado: (2017)

Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
por: Eberhardt, Hannes U., et al.
Publicado: (2013)

Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation
por: Poillerat, Victoria, et al.
Publicado: (2020)

Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies
por: Irmscher, Sarah, et al.
Publicado: (2019)

Anaphylatoxins Activate Ca(2+), Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
por: Busch, Catharina, et al.
Publicado: (2017)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

A Novel Antibody against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin from Blood Samples
por: Pauly, Diana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_veb52gvcvd9odp82518jrfsg3o